Tech Company Financing Transactions
PulseSight Therapeutics Funding Round
PulseSight Therapeutics, based in Paris, secured investment capital from ND Capital, Pureos Bioventures and Korea Investment Partners.
Transaction Overview
Company Name
Announced On
2/28/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Biopark, 11 Rue Watt Bat B
Paris, 75013
France
Paris, 75013
France
Phone
Website
Email Address
Overview
PulseSight Therapeutics is pioneering a unique approach to administer disease-modifying genes through its proprietary electro-transfection delivery device. Our innovative therapies offer longer-acting as well as more effective options than current treatments, addressing multiple pathways involved in the disease process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Judith Greciet
Chief Medical Officer
Marina Iche
Chief Scientific Officer
Thierry Bordet
VP - Finance
Gina Pinto
Browse more venture capital transactions:
Prev: 2/28/2024: Robovision venture capital transaction
Next: 2/28/2024: Zeno Health venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs